-
GSK3368715 dihydrochloride
- names:
GSK3368715 dihydrochloride
- CAS号:
1628925-77-8
MDL Number: - MF(分子式): C20H40Cl2N4O2 MW(分子量): 439.46
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM003018-5mg | 5mg | 99.49% | ¥ 6075.00 | ¥ 6075.00 | 2-3天 | ¥ 0.00 | ||
| YZM003018-1mg | 1mg | 99.49% | ¥ 2600.00 | ¥ 2600.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1628925-77-8 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C20H40Cl2N4O2 |
| 分子量 Molecular Weight | 439.46 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度250 mg/mL(568.88 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 4°C, stored under nitrogen * In solvent : -80°C, 6 months月; -20°C, 1 month月 (stored under nitrogen) |
GSK3368715 dihydrochloride(CAS:1628925-77-8)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) 为具有口服活性的,可逆的,SAM 非竞争性 I 型蛋白精氨酸甲基转移酶(PRMTs)抑制剂 (IC50=3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8)) |
| Introduction | GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active, reversible, and Sdenosylethionine (SAM) uncompetitivetype I protein arginine methyltransferases (PRMTs)inhibitor (IC50=3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8)). GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) produces a shift in arginine methylation states, alters exon usage, and has strong antiancer activity. |
| Application1 | |
| Application2 | |
| Application3 |
GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) 为具有口服活性的,可逆的,SAM 非竞争性 I 型蛋白精氨酸甲基转移酶(PRMTs)抑制剂 (IC50=3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8))。GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) 导致精氨酸甲基化状态的转变,改变了外显子的使用,具有很强的抗癌活性。GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active, reversible, and S-adenosyl-L-methionine (SAM) uncompetitivetype I protein arginine methyltransferases (PRMTs)inhibitor (IC50=3.1 nM (PRMT1), 48 nM (PRMT3), 1148 nM (PRMT4), 5.7 nM (PRMT6), 1.7 nM (PRMT8)). GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) produces a shift in arginine methylation states, alters exon usage, and has strong anti-cancer activity[1].
【1】.Fedoriw A, et al. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss. Cancer Cell. 2019 Jul 8;36(1):100-114.e25.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


